
LongeVC
Europe, Ticino, Switzerland, Lugano
Description
LongeVC is an early-stage venture firm that focuses on high-impact investments in biotechnology and healthcare.
Investor Profile
LongeVC has backed more than 19 startups, with 4 new investments in the last 12 months alone. The firm has led 5 rounds, about 26% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Hong Kong.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 2 rounds in the past year.
Stage Focus
- Seed (42%)
- Series A (37%)
- Series Unknown (16%)
- Pre Seed (5%)
Country Focus
- United States (63%)
- United Kingdom (11%)
- Hong Kong (5%)
- Estonia (5%)
- Switzerland (5%)
- Canada (5%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Health Diagnostics
- Medical Device
- Artificial Intelligence (Ai)
- Genetics
- Medical
- Information Services
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does LongeVC frequently co-invest with?
Which angels does LongeVC often collaborate with?
What are some of recent deals done by LongeVC?
Find More Investors Like LongeVC
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









